ํํ ๋ฐ๋ฅด๋นํ ๋ํธ๋ฅจ
ํํ ๋ฐ๋ฅด๋นํ ๋ํธ๋ฅจ์ ์์ํ์์ ์ ์ ๋ง์ทจ์ ๋ฐ ์ง์ ์ ๋ก ์ญ์ฌ์ ์ผ๋ก ์ฌ์ฉ๋ ๋จ๊ธฐ ์์ฉ **๋ฐ๋ฅด๋นํฌ๋ฅด์ฐ์ผ**์ ๋๋ค. ๋ ์์ ํ ํก์ ๋ง์ทจ์ ์ ํ๋กํฌํด ๊ฐ์ ์ฃผ์ฌ์ ์ ๋ฑ์ฅ์ผ๋ก ์ธํด, ํ์ฌ ์น๋ฃ์ ์ฉ๋๋ ์ฃผ๋ก **๋์น์ฑ ๊ฐ์ง ์ค์ฒฉ์ฆ**(์: ์คํธ๋ฆฌํฌ๋ ๋๋ ํ์ํ ๋ ์ฑ์ผ๋ก ์ธํ ์ด์ฐจ์ ๋ฐ์) ๊ด๋ฆฌ ๋ฐ **์๋ฝ์ฌ ์ฉ์ก**์ ์ฃผ์ ์ฑ๋ถ์ผ๋ก ์ ํ๋ฉ๋๋ค. * **์ค์ถ์ ๊ฒฝ๊ณ ์ต์ :** ๊ฐ๋ฒผ์ด ์ง์ ์์ ๊น์ ํผ์ ๋ฐ ์ฌ๋ง์ ์ด๋ฅด๊ธฐ๊น์ง ๋ชจ๋ ์์ค์ ์ค์ถ์ ๊ฒฝ๊ณ ๋ณํ๋ฅผ ์ ๋ฐํ ์ ์์ต๋๋ค. * **์ฌํ๊ด๊ณ ๋ฐ ํธํก๊ธฐ ์ํฅ:** ์ฉ๋ ์์กด์ ์ธ ํธํก ์ต์ ๋ฐ ์ฌํ๊ด๊ณ ๋ณํ(๋น๋งฅ, ์ฌ๊ทผ ์์ถ๋ ฅ ๊ฐ์, ์ ํ์)๋ฅผ ์ ๋ฐํฉ๋๋ค. > **์์ ์์ :** ํํ ๋ฐ๋ฅด๋นํ์ ์น๋ฃ ์ง์๊ฐ ์ข์ผ๋ฉฐ **๋ณธ์ง์ ์ธ ์งํต ํจ๊ณผ๊ฐ ์์ต๋๋ค**. (์๋ฝ์ฌ ๋ณตํฉ์ ๋ก ์กฐ์ ๋์ง ์์ ๊ฒฝ์ฐ) DEA ์ค์ผ์ค II ํต์ ์ฝ๋ฌผ์ ๋๋ค.
์์ฉ ๊ธฐ์ : Pentobarbital acts as a profound **CNS depressant** through multiple mechanisms: * **GABA-A Receptor Modulation:** Binds to the barbiturate site on the GABA-A receptor, **prolonging the duration** of chloride channel opening โ hyperpolarization of the postsynaptic membrane โ profound CNS inhibition. At high doses, it is directly GABA-mimetic. * **Glutamate Inhibition:** Inhibits excitatory neurotransmission by blocking glutamate release and AMPA/kainate receptors. * **Neurotransmitter Release:** Inhibits the release of acetylcholine and norepinephrine. * **Calcium Channels:** At high anesthetic doses, it inhibits calcium uptake at nerve terminals.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Known hypersensitivity to barbiturates
- Severe liver disease
- Nephritis
- Severe respiratory depression
- Lidocaine-induced seizures
- Pregnancy (Category D - embryotoxic/teratogenic)
์ด์๋ฐ์
- Respiratory depression (can be severe)
- Hypothermia
- Paradoxical excitement during recovery (especially in dogs)
- Cardiovascular depression (decreased contractility, hypotension)
- Severe tissue irritation and necrosis (if given perivascularly or SC)
์ฝ๋ฌผ ์ํธ์์ฉ
- Acetaminophen ยท Increased risk for hepatotoxicity, particularly with large or chronic barbiturate doses.
- Lidocaine ยท Fatalities reported when treating lidocaine-induced seizures with pentobarbital; use diazepam instead.
- Phenytoin ยท Barbiturates may affect phenytoin metabolism and vice versa; blood level monitoring indicated.
- Rifampin ยท May induce enzymes that increase the metabolism of barbiturates.
- Antihistamines ยท May increase the CNS depressant effect of pentobarbital.
- Chloramphenicol ยท May increase the CNS depressant effect of pentobarbital.
- Opiates ยท May increase the CNS depressant effect of pentobarbital.
- Phenothiazines ยท May increase the CNS depressant effect of pentobarbital.
๋ชจ๋ํฐ๋ง
- Respiratory rate, depth, and effort (ventilatory support must be available)
- Heart rate and rhythm
- Blood pressure
- Body temperature (monitor for hypothermia)
- Depth of anesthesia/sedation
๊ณผ์ฉ๋
In dogs, the reported oral LD50 is 85 mg/kg and IV LD50 is 40-60 mg/kg. **Fatalities from ingestion of meat from animals euthanized by pentobarbital have been reported in dogs.** **Treatment:** * Removal of ingested product from the gut if appropriate (e.g., gastric lavage, activated charcoal). * Provide aggressive respiratory (ventilatory) and cardiovascular support. * Forced alkaline diuresis is of little benefit. * Peritoneal dialysis or hemodialysis may be beneficial in severe intoxications.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.